Pulmatrix Inc (PULM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.71M
Last updated: Nov 17, 2026 at 4:24 PM ET
Pulmatrix Inc (PULM) Statistics
Pulmatrix (PULM) has a market cap of $4.71M and an enterprise value of $3.31M. Revenue fell 100.00% over the last 12 months from the 12 months before. It holds $1.40M more cash than debt, 29.67% of its market cap.
Total Valuation
Enterprise value is 29.67% below the market cap, as cash exceeds debt.
| Market Cap | $4.71M |
|---|---|
| Enterprise Value | $3.31M |
| Latest price (Nov 17, 2026) | $1.37 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 70.91% over 52 weeks and trades 6.16% below its 50-day average.
| Beta (1Y) | 0.22 |
|---|---|
| 52-Week Change | -70.91% |
| 1-Month Change | -3.52% |
| 3-Month Change | -9.87% |
| 6-Month Change | +8.73% |
| 5-Year Change | -91.95% |
| 10-Year Change | -99.45% |
| Total Return (1Y) | -70.91% |
| Total Return (3Y CAGR) | -8.95% |
| Total Return (5Y CAGR) | -37.61% |
| Return vs SPY (1Y) | -81.11% |
| Max Drawdown (1Y) | -74.95% |
| Max Drawdown (3Y) | -88.12% |
| Sharpe Ratio (1Y) | -1.22 |
| Correlation with SPY (1Y) | 0.03 |
| 50-Day Average | $1.46 |
| 200-Day Average | $1.63 |
| 52-Week Range | $1.06 to $4.94 |
| RSI (14 Days) | 47.5 |
| Average Volume (20 Days) | 37.19K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.32x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 2.32x |
|---|---|
| Quick Ratio | 2.32x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -323.11% over the last 12 months, against a 5-year average of -84.77%.
| Return on Equity (ROE) | -323.11% |
|---|---|
| Return on Assets (ROA) | -184.05% |
| ROE (5Y Average) | -84.77% |
| ROA (5Y Average) | -68.55% |
Scores
PULM has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$4.47M |
| Pretax Income | -$4.35M |
| Net Income | -$4.35M |
| Reported EPS (TTM) | -$1.10 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 57.20% of the $2.36M in total assets.
| Cash and Equivalents | $1.40M |
|---|---|
| Total Debt | $0 |
| Net Cash | $1.40M |
| Net Cash Per Share | $0.38 |
| Working Capital | $1.34M |
| Shareholder Equity | $1.35M |
| Book Value Per Share | $0.10 |
| Total Assets | $2.36M |
| Total Liabilities | $1.02M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$3.65M |
|---|---|
| FCF Per Share | -$1.00 |
Trailing 12 months through Sep 30, 2026.
Stock Splits
The last split was a 1-for-20 reverse split on Mar 1, 2022.
| Last Split Date | Mar 1, 2022 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About PULM
What is PULM's market cap?
Pulmatrix has a market cap of $4.71M. Its enterprise value, which adds debt and subtracts cash, is $3.31M.
How many shares of PULM are outstanding?
Pulmatrix has 3.65M shares outstanding. The count is up 0.00% from a year earlier.
Does PULM pay a dividend?
No. Pulmatrix does not pay a dividend.
How much debt does PULM have?
Pulmatrix has $0 of total debt and $1.40M of cash and equivalents, a net cash position of $1.40M.
PULM pages: Overview, Charting, Earnings, Financials, Statistics, Competitors